SQSTM1 and Alzheimer disease: The LG-M group showed an increase in Beclin-1 expression (p < 0.01 vs. AD) and a decrease in p62 expression (p < 0.05 vs. AD), while the increase of LC3 II expression was not statistically significant (p > 0.05 vs. AD).